1 Mokdad AH, Ford ES, Bowman BA, et al. (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289, 76–79.
2 Kahn SE, Hull RL & Utzscheider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444, 840–846.
3 Ritchie SA & Connell JMC (2007) The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis 17, 319–326.
4 Baron AD, Bretchel G, Wallace P, et al. (1988) Rates and tissue sites of non-insulin and insulin-mediated glucose uptake in humans. Am J Physiol 255, E769–E774.
5 Shulman GI (2000) Cellular mechanisms of insulin resistance. J Clin Invest 106, 171–175.
6 McGarry JD (2002) Banting lecture: 2001: dysregulation of fatty acid metabolism in the aetiology of type 2 diabetes. Diabetes 51, 7–18.
7 Roden M, Price TB, Perseghin G, et al. (1996) Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97, 2859–2865.
8 Dresner A, Laurent D, Marcucci M, et al. (1998) Effects of free fatty acids on glucose transport and IRS1-associated phophatidylinositol 3-kinase activity. J Clin Invest 103, 253–259.
9 Kruszynska YT, Worrall DS, Ofrecio J, et al. (2002) Fatty acid-induced insulin resistance: decreased muscle PI3K activation but unchanged Akt phosphorylation. J Clin Endocrinol Metab 87, 226–234.
10 Lee JS, Pinnamaneni SK, Eo SJ, et al. (2006) Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites. J Appl Physiol 100, 1467–1474.
11 Van Epps-Fung M, Williford J, Wells A, et al. (1997) Fatty acid-induced insulin resistance in adipocytes. Endocrinology 138, 4338–4345.
12 Chavez JA & Summers SA (2003) Characterizing the effects of saturated fatty acids on insulin signalling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Arch Biochem Biophys 419, 101–109.
13 Sabin MA, Stewart CE, Crowne EC, et al. (2007) Fatty acid-induced defects in insulin signalling, in myotubes derived from children, are related to ceramide production from palmitate rather than the accumulation of intramyocellular lipid. J Cell Physiol 211, 244–252.
14 Pickersgill L, Litherland GJ, Greenberg AS, et al. (2007) Key role for ceramides in mediating insulin resistance in human muscle cells. Biochem J 282, 12583–12589.
15 Coll T, Eyre E, Rodriguez-Calvo R, et al. (2008) Oleate reverses palmitate-induced insulin resistance and inflammation in skeletal muscle cells. J Biol Chem 283, 11107–11116.
16 Bailey CJ, Turner SL, Bates SH, et al. (2001) Sibutramine metabolites increase glucose transport by cultured rat muscle cells. Int J Obes Relat Metab Disord 25, 478–485.
17 Zhang WY, Schwartz E, Wang YJ, et al. (2006) Elevated concentrations of nonesterified fatty acids increase monocyte expression of CD11b and adhesion to endothelial cells. Arterioscler Thromb Vasc Biol 26, 514–519.
18 Gao D (2009) Palmitate induces insulin resistance and a pro-atherogenic phenotype in monocytes. .
19 Bailey CJ & Turner SL (2004) Glucosamine-induced insulin resistance in L6 muscle cells. Diabetes Obes Metab 6, 293–298.
20 Nicholson DW, Ali A, Thornberry NA, et al. (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376, 37 − 43.
21 Smith PK, Krohn RI, Hermanson GT, et al. (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150, 76–85.
22 Toker A & Cantley CL (1997) Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 387, 673–676.
23 Sinha S, Perdomo G, Brown NF, et al. (2004) Fatty acid-induced insulin resistance in L6 myotubes is prevented by inhibition of activation and nuclear localization of nuclear factor κB. J Biol Chem 279, 41294–41301.
24 Boden G, Chen X, Ruiz J, et al. (1994) Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93, 2423–2446.
25 Kolesnick RN & Krönke M (1998) Regulation of ceramide production and apoptosis. Annu Rev Physiol 60, 643–665.
26 Hajduch E, Balendran A, Batty IH, et al. (2001) Ceramide impairs the insulin-dependent membrane recruitment of protein kinase B leading to a loss of downstream signalling in L6 skeletal muscle cells. Diabetologia 44, 173–183.
27 Summers SA, Garza LA, Zhou H, et al. (1998) Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide. Mol Cell Biol 18, 5457–5464.
28 Schmitz-Peiffer C, Craig DL & Biden TJ (1999) Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J Biol Chem 274, 24202–24210.
29 Chavez JA, Knotts TA, Wang LP, et al. (2003) A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 278, 10297–10303.
30 Powell D, Turban S, Gray A, et al. (2004) Intracellular ceramide synthesis and protein kinase Cζ activation play an essential role in palmitate-induced insulin resistance in rat L6 skeletal muscle cells. Biochem J 382, 619–629.
31 Itani SI, Ruderman NB, Schmieder F, et al. (2002) Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-α. Diabetes 51, 2005–2011.
32 Griffin ME, Marcucci MJ, Cline GW, et al. (1999) Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signalling cascade. Diabetes 48, 1270–1274.
33 Karlsson HKR & Zierath JR (2007) Insulin signalling and glucose transport in insulin resistant human skeletal muscle. Cell Biochem Biophys 48, 103–113.
34 Hardy S, Langelier Y & Prentki M (2000) Oleate activates phosphatidylinositol 3-kinase and promotes proliferation and reduces apoptosis of MDA-MB-231 breast cancer cells, whereas palmitate has opposite effects. Cancer Res 60, 6353–6358.
35 Kim JK, Fillmore JJ, Sunshine MJ, et al. (2004) PKC-θ knockout mice are protected from fat-induced insulin resistance. J Clin Invest 114, 823–827.
36 Massaro M, Carluccio MA, Paolicchi A, et al. (2002) Mechanisms for reduction of endothelial activity by oleate: inhibition of nuclear factor-κB through antioxidant effects. Prostaglandins Leukot Essent Fatty Acids 67, 175–181.
37 Voshol PJ, Jong MC, Dahlmans VE, et al. (2001) In muscle-specific lipoprotein lipase-overexpressing mice, muscle triglyceride content is increased without inhibition of insulin-stimulated whole-body and muscle-specific glucose uptake. Diabetes 50, 2585–2590.
38 Conp M, Hannaert JC, Hoorrens A, et al. (2001) Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. Diabetes 50, 1771–1777.
39 Listenberger LL, Han XL, Lewis SE, et al. (2003) Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci U S A 100, 3077–3082.
40 Kelly DE, He J, Menshikova EV, et al. (2002) Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51, 2944–2950.
41 Ros E (2003) Dietary cis-monounsaturated fatty acids and metabolic control in type 2 diabetes. Am J Clin Nutr 78, Suppl. 3, 617S–625S.
42 Garg A (1998) High-monounsaturated-fat diets for patients with diabetes mellitus: a meta-analysis. Am J Clin Nutr 67, Suppl. 3, 577S–582S.
43 Due A, Larsen TM, Hermansen K, et al. (2008) Comparison of the effects on insulin resistance and glucose tolerance of 6-month high-monounsaturated-fat, low-fat, and control diets. Am J Clin Nutr 87, 855–862.